clofibrate has been researched along with Hypercholesterolemia in 247 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of colestipol HCl resin and clofibrate on plasma lipid and lipoprotein levels were compared in 65 patients with primary hypercholesterolemia." | 9.05 | Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia. ( Berns, L; Eder, HA; Goodman, DS; Seplowitz, AH; Smith, FR, 1981) |
| "Twenty subjects with familial hypercholesterolemia (12 Type IIa and 8 Type IIb), previously treated with Colestipol for 16 months, were subjected to therapy with Colestipol (15 g/day) + clofibrate (2 g/day) for 15 months." | 9.04 | Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia. ( Baggio, G; Baiocchi, MR; Baldo, G; Briani, G; Crepaldi, G; Fellin, R; Manzato, E, 1978) |
| "The study was designed to characterise the influence of a novel acyl-CoA:cholesterol acyltransferase inhibitor, VULM 1457, on the severity of myocardial ischaemia-reperfusion injury in a model of diabetes mellitus and hypercholesterolaemia induced by co-administration of streptozotocin and a high fat-cholesterol diet." | 7.74 | The myocardial infarct size-limiting and antiarrhythmic effects of acyl-CoA:cholesterol acyltransferase inhibitor VULM 1457 protect the hearts of diabetic-hypercholesterolaemic rats against ischaemia/reperfusion injury both in vitro and in vivo. ( Adameová, A; Faberová, V; Kuzelová, M; Ravingerová, T; Svec, P, 2007) |
| "In a pilot study the therapeutic effect of 2 x 500 mg etofibrate (Lipo Merz retard) on lipids and lipoproteins, fibrinolytic activity and clinical parameters was studied for four weeks in hyperlipidemic patients suffering from arteriosclerosis obliterans (Fontaine stage II/III)." | 7.67 | [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. ( Basista, M; Bieroń, K; Czarnecka, H; Dembińska-Kieć, A; Grodzińska, L; Kedzior, A; Kostka-Trabka, E; Slawiński, M; Trabka, E; Zmuda, A, 1989) |
| "Some patients with familial hypercholesterolemia (FHC, type II) are highly responsive to the cholesterol-lowering effect of clofibrate, while others are not only resistant to this effect but may even show an increase in plasma beta-lipoproteins." | 7.65 | Pharmacokinetics of clofibrate in familial hypercholesterolemia. ( Boulet, L; Davignon, J; Pichardo, R, 1977) |
| "This study was designed to compare the ability of distal intestinal bypass versus clofibrate administration to prevent the development of atherosclerosis and hypercholesterolemia in monkeys on a standardized atherogenic regimen." | 7.65 | Protective effects of ileal bypass versus administration of clofibrate on experimental hypercholesterolemia and atherosclerosis in monkeys. ( Butts, WH; Curtis, JJ; Scott, HW; Younger, RK, 1976) |
| "A patient with primary biliary cirrhosis is reported in whom the administration of clofibrate in a dose of 1 g per day for 2 months resulted in a marked increase in hypercholesterolemia, and endoscopic retrograde cholangiography showed multiple intrahepatic gallstones." | 7.65 | Effects of clofibrate in primary biliary cirrhosis hypercholesterolemia and gallstones. ( Elias, E; Sherlock, S; Summerfield, JA, 1975) |
| "Clofibrate was administered to 5 selected outpatients suffering from type IIa hyperlipoproteinaemia who had previously undergone dietetic treatment, and one female patient suffering from hypo-HDL-aemia in order to elucidate the question as to whether medium long term clofibrate therapy apart from producing an initial increase relative to the LDL concentration may also lead to an absolute increase in the concentration of HDL cholesterol in serum." | 5.26 | [Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate]. ( Mertz, DP, 1980) |
| "The effects of colestipol HCl resin and clofibrate on plasma lipid and lipoprotein levels were compared in 65 patients with primary hypercholesterolemia." | 5.05 | Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia. ( Berns, L; Eder, HA; Goodman, DS; Seplowitz, AH; Smith, FR, 1981) |
| "The effect of essential phospholipids in combination with Clofibrate (N 041) was compared with that of Clofibrate alone in a double blind study in 96 patients with hypertriglyceridemia and/or hypercholesterolemia." | 5.04 | [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate]. ( Gaertner, U; Johannes, KJ, 1976) |
| "Twenty subjects with familial hypercholesterolemia (12 Type IIa and 8 Type IIb), previously treated with Colestipol for 16 months, were subjected to therapy with Colestipol (15 g/day) + clofibrate (2 g/day) for 15 months." | 5.04 | Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia. ( Baggio, G; Baiocchi, MR; Baldo, G; Briani, G; Crepaldi, G; Fellin, R; Manzato, E, 1978) |
| "The study was designed to characterise the influence of a novel acyl-CoA:cholesterol acyltransferase inhibitor, VULM 1457, on the severity of myocardial ischaemia-reperfusion injury in a model of diabetes mellitus and hypercholesterolaemia induced by co-administration of streptozotocin and a high fat-cholesterol diet." | 3.74 | The myocardial infarct size-limiting and antiarrhythmic effects of acyl-CoA:cholesterol acyltransferase inhibitor VULM 1457 protect the hearts of diabetic-hypercholesterolaemic rats against ischaemia/reperfusion injury both in vitro and in vivo. ( Adameová, A; Faberová, V; Kuzelová, M; Ravingerová, T; Svec, P, 2007) |
| "This study examined the effects of simvastatin (10 mg/ kg) and VULM 1457 (50 mg/kg), an ACAT inhibitor, in the heart model of 6 min ischemia followed by 10 min reperfusion injury in the diabetic-hypercholesterolaemic (DM-HCH) rats." | 3.73 | Protective effect of simvastatin and VULM 1457 in ischaemic-reperfused myocardium of the diabetic-hypercholesterolemic rats. ( Adameová, A; Faberová, V; Kuzelová, M; Svec, P, 2006) |
| "(1) In primary prevention trials, pravastatin and lovastatin prevented myocardial infarction and had a positive risk-benefit ratio in men with LDL-cholesterol values exceeding 4." | 3.70 | Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention. ( , 1999) |
| "The authors describe the neurological manifestations of a female patient with hypercholesterolemia who developed myopathy in the course of her treatment with clofibrate." | 3.68 | [Iatrogeny. The importance of clinical diagnosis. Myopathies induced by clofibrate]. ( Balassiano, SL; Godoy, JM; Nicaretta, DH; Skacel, M, 1992) |
| "In a pilot study the therapeutic effect of 2 x 500 mg etofibrate (Lipo Merz retard) on lipids and lipoproteins, fibrinolytic activity and clinical parameters was studied for four weeks in hyperlipidemic patients suffering from arteriosclerosis obliterans (Fontaine stage II/III)." | 3.67 | [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. ( Basista, M; Bieroń, K; Czarnecka, H; Dembińska-Kieć, A; Grodzińska, L; Kedzior, A; Kostka-Trabka, E; Slawiński, M; Trabka, E; Zmuda, A, 1989) |
| "A 16 days clofibride treatment in hyperlipaemic rabbit (fat supply), reduces hypertriglyceridemia and hypercholesterolemia." | 3.66 | [Potentiation by clofibride of the heparin-induced clearing reaction (intravascular hydrolysis of neutral lipids), in hyperlipemic rabbits]. ( Benouniche, N; Drif, M; Elsair, J; Ghouini, A; Iklef, F; Khelfat, K; Marquie, G; Tabet Aoul, FS; Tabet Aoul, M, 1982) |
| " It is suggested that the liver lesions of this woman may be related to long-term administration of hypolipidemic drug clofibrate for hypercholesteremia and the lesions could be one of the precursor changes of human hepatocellular carcinoma." | 3.66 | Adenoma with multiple hyperplastic nodules in noncirrhotic liver possibly related to long-term administration of a hypolipidemic drug. ( Mori, H; Sugie, S; Takahashi, M; Tanaka, T, 1982) |
| "Some patients with familial hypercholesterolemia (FHC, type II) are highly responsive to the cholesterol-lowering effect of clofibrate, while others are not only resistant to this effect but may even show an increase in plasma beta-lipoproteins." | 3.65 | Pharmacokinetics of clofibrate in familial hypercholesterolemia. ( Boulet, L; Davignon, J; Pichardo, R, 1977) |
| "This study was designed to compare the ability of distal intestinal bypass versus clofibrate administration to prevent the development of atherosclerosis and hypercholesterolemia in monkeys on a standardized atherogenic regimen." | 3.65 | Protective effects of ileal bypass versus administration of clofibrate on experimental hypercholesterolemia and atherosclerosis in monkeys. ( Butts, WH; Curtis, JJ; Scott, HW; Younger, RK, 1976) |
| "A patient with primary biliary cirrhosis is reported in whom the administration of clofibrate in a dose of 1 g per day for 2 months resulted in a marked increase in hypercholesterolemia, and endoscopic retrograde cholangiography showed multiple intrahepatic gallstones." | 3.65 | Effects of clofibrate in primary biliary cirrhosis hypercholesterolemia and gallstones. ( Elias, E; Sherlock, S; Summerfield, JA, 1975) |
| " The patients were divided into two groups at random and in each case received 3 X 50, 3 X 100, 3 X 150 and 3 X 200 mg bezafibrate daily in increasing or falling dosage for four weeks." | 2.65 | [Dose-effects studies with bezafibrate in patients with hypercholesterolemia and hypertriglyceridemia (author's transl)]. ( Adam, O; Lang, PD; Wolfram, G; Zöllner, N, 1979) |
| "Uric acid was significantly reduced only during the first period of treatment (p less than 0." | 2.64 | Clofibrate in type II hyperlipoproteinemia. ( Bang, HO; Ditzel, J, 1976) |
| "When clofibrate was added, a further decrease of plasma cholesterol by 6% was observed, and the levels of triglycerides were reduced." | 2.64 | Effect of treatment with a bile-sequestering agent (Secholex) on intestinal absorption, duodenal bile acids, and plasma lipids. ( Blomhoff, JP; Fausa, O; Gjone, E; Lanner, A; Ritland, S; Skrede, S, 1975) |
| "Therefore clinicians treating coronary artery disease need to emphasize secondary prevention and recognize the key role of cholesterol-lowering therapy." | 2.40 | [Prevention of coronary heart disease--"evidence-based medicine" of antilipemic therapy]. ( Herzum, M; Maisch, B; Schaefer, JR, 1999) |
| "VULM 1457 is an ACAT inhibitor, which has expressed potent hypolipidemic and antiatherosclerotic effects in previous studies." | 1.33 | The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats. ( Adameová, A; Faberová, V; Kuzelová, M; Svec, P, 2005) |
| "The clofibrate supplement was used as a positive control for the lipid-lowering efficacy." | 1.33 | Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats. ( Bok, SH; Choi, MS; Kim, HJ; Kim, SJ; Lee, MK; Lee, S; Park, YB, 2005) |
| "Clofibrate treatment significantly reduced the content of esterified cholesterol in this vessel." | 1.27 | Influence of clofibrate on the plasma lipoprotein pattern and on the lipid content and protein and collagen synthesis in atherosclerotic coronary arteries and abdominal aorta from hypercholesterolemic mini-pigs. ( Jacobsson, L, 1987) |
| "Clofibrate was given after operation to one patient, and cholic acid to both, in an effort to enhance further the negative sterol balance." | 1.26 | Failure of complete bile diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia. ( Deckelbaum, RJ; Grundy, SM; Hedberg, SE; Lees, RS; Small, DM, 1977) |
| " Applications are given to a comparative bioavailability trial for attainment of steady state levels and to a clinical trial to compare the effects of two hypolipidemics." | 1.26 | The analysis of the two-period repeated measurements crossover design with application to clinical trials. ( Fisher, AC; Wallenstein, S, 1977) |
| "Although the diagnosis of hyperlipidemia is somewhat arbitrary, in that the upper limits of normal are not universally agreed upon, it is clear that the risk of atherosclerosis increases with plasma cholesterol concentration; it may also increase in hyperglyceridemia." | 1.26 | Therapy of the hyperlipidemias. ( Lees, AM; Lees, RS, 1976) |
| "If the hypercholesterolemia was continued for 18 months, no significant change in the cholesterol ester content in the aorta occurred; in the coronary arteries there was a significant decrease in these older pigs." | 1.26 | Experimental atherosclerosis in hypercholesterolemic mini-pigs. Regression of cholesterol ester accumulation in aorta and coronary arteries after treatment with clofibrate, beta-pyridylcarbinol or a normo-lipidemic diet. ( Jacobsson, L; Lundholm, L, 1982) |
| "Clofibrate was administered to 5 selected outpatients suffering from type IIa hyperlipoproteinaemia who had previously undergone dietetic treatment, and one female patient suffering from hypo-HDL-aemia in order to elucidate the question as to whether medium long term clofibrate therapy apart from producing an initial increase relative to the LDL concentration may also lead to an absolute increase in the concentration of HDL cholesterol in serum." | 1.26 | [Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate]. ( Mertz, DP, 1980) |
| "Clofibrate treatment resulted in significant increases in the volumes of the hepatocytes and their constituent mitochondria and microbodies and caused a proliferation of the smooth-surfaced endoplasmic reticulum." | 1.26 | A quantitative analysis of fine structure and drug metabolism in livers of clofibrate-treated young adult and retired breeder rats. ( Anthony, LE; Jones, AL; Mooney, JS; Schmucker, DL, 1978) |
| "Clofibrate treatment did not affect serum lipid levels significantly in either normal or cholesterol-fed mice." | 1.26 | Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice. ( Abiko, Y; Nakayasu, T; Tawara, K; Tomikawa, M, 1981) |
| " Nicotinic acid in the form of niceritrol had another type of dose-response in type II with doses from 3 to 6 g/day." | 1.25 | Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. ( Carlson, LA; Olsson, AG; Orö, L; Rössner, S, 1975) |
| " This conclusion was strengthened by finding that long-term administration of the drug can cause marked reduction in body pools of cholesterol." | 1.25 | Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. ( Ahrens, EH; Grundy, SM; Nestel, PJ; Salen, G; Schreibman, PH, 1972) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 226 (91.50) | 18.7374 |
| 1990's | 15 (6.07) | 18.2507 |
| 2000's | 5 (2.02) | 29.6817 |
| 2010's | 1 (0.40) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chinn, LJ | 1 |
| Salamon, KW | 1 |
| Fenton, G | 1 |
| Newton, CG | 1 |
| Wyman, BM | 1 |
| Bagge, P | 1 |
| Dron, DI | 1 |
| Riddell, D | 1 |
| Jones, GD | 1 |
| Cozzi, P | 2 |
| Branzoli, U | 2 |
| Lovisolo, PP | 2 |
| Orsini, G | 1 |
| Carganico, G | 2 |
| Pillan, A | 1 |
| Chiari, A | 2 |
| Oliver, MF | 5 |
| Corvol, JC | 1 |
| Bouzamondo, A | 1 |
| Sirol, M | 1 |
| Hulot, JS | 1 |
| Sanchez, P | 1 |
| Lechat, P | 1 |
| ROBERTS, SD | 1 |
| HAYES, D | 1 |
| PANTRIDGE, JF | 1 |
| SUZMAN, MM | 1 |
| BERSOHN, I | 2 |
| ROGEN, AS | 1 |
| FERGUSON, JC | 1 |
| WILLIAMS, GE | 2 |
| MEYNELL, MJ | 1 |
| PROUT, BJ | 1 |
| EDWARDS, EA | 1 |
| PRIOR, IA | 1 |
| CAMPBELL, DG | 1 |
| BORRIE, P | 1 |
| STRISOWER, EH | 1 |
| STRISOWER, B | 1 |
| ENGSTROEM, J | 1 |
| BARNETT, AJ | 1 |
| CARSON, V | 1 |
| DE MEIRING, PV | 1 |
| VASTESAEGER, M | 2 |
| GILLOT, P | 1 |
| DELCOURT, R | 1 |
| MASON, B | 1 |
| PERRY, CB | 1 |
| MISHKEL, MA | 2 |
| FELT, V | 3 |
| STARKA, L | 2 |
| BEDNAR, J | 2 |
| SZNAJDERMAN, M | 2 |
| CISWICKA SZNAJDERMAN, M | 2 |
| IGNATOWSKA, H | 2 |
| GAJEWSKI, J | 2 |
| SKORYKOW, A | 2 |
| SULCOVA, J | 1 |
| OGSTON, CM | 1 |
| OGSTON, D | 1 |
| MCANDREW, GM | 1 |
| PEAK, HJ | 1 |
| MITCHELL, AS | 1 |
| JOSE, AD | 1 |
| Kim, SJ | 1 |
| Bok, SH | 1 |
| Lee, S | 1 |
| Kim, HJ | 1 |
| Lee, MK | 1 |
| Park, YB | 1 |
| Choi, MS | 1 |
| Adameová, A | 3 |
| Kuzelová, M | 3 |
| Faberová, V | 3 |
| Svec, P | 3 |
| Ravingerová, T | 1 |
| Elsair, J | 1 |
| Marquie, G | 1 |
| Drif, M | 1 |
| Khelfat, K | 1 |
| Benouniche, N | 1 |
| Tabet Aoul, M | 1 |
| Tabet Aoul, FS | 1 |
| Iklef, F | 1 |
| Ghouini, A | 1 |
| Donatelli, L | 1 |
| Miettinen, TA | 2 |
| Mori, H | 1 |
| Tanaka, T | 1 |
| Sugie, S | 1 |
| Takahashi, M | 1 |
| Stamler, J | 1 |
| Słowińska, R | 1 |
| Bochenek, W | 1 |
| Unlot, J | 1 |
| Ohata, I | 1 |
| Sakamoto, N | 1 |
| Nagano, K | 1 |
| Maeno, H | 1 |
| Jacobsson, L | 2 |
| Lundholm, L | 1 |
| Mordasini, R | 2 |
| Riesen, W | 1 |
| Oster, P | 1 |
| Keller, M | 1 |
| Middelhoff, G | 2 |
| Lang, PD | 2 |
| Kitazaki, T | 1 |
| Tsuda, M | 1 |
| Matsumura, H | 1 |
| Ohtagaki, T | 1 |
| Imai, Y | 1 |
| Odumosu, A | 2 |
| Hanck, A | 1 |
| Altman, RF | 1 |
| Fidanza, A | 1 |
| Greco-Ferrante, A | 1 |
| La Rocca, L | 1 |
| Wilson, CW | 1 |
| Tomikawa, M | 1 |
| Nakayasu, T | 1 |
| Tawara, K | 1 |
| Abiko, Y | 1 |
| Seplowitz, AH | 1 |
| Smith, FR | 1 |
| Berns, L | 1 |
| Eder, HA | 1 |
| Goodman, DS | 1 |
| Hendrickson, RM | 1 |
| Simpson, F | 1 |
| Davignon, J | 3 |
| Lussier-Cacan, S | 1 |
| Dubreuil-Quidoz, S | 1 |
| LeLorier, J | 1 |
| Reuter, W | 2 |
| Fringes, B | 1 |
| Riede, UN | 1 |
| von Deimling, O | 1 |
| Pasquali, R | 1 |
| Melchionda, N | 1 |
| Parenti, M | 1 |
| Cavazzini, MG | 1 |
| Biso, P | 1 |
| Baraldi, G | 1 |
| Sorrenti, G | 1 |
| De Benedittis, G | 1 |
| Labò, G | 1 |
| Fabbrocini, V | 1 |
| Mertz, DP | 4 |
| Gould, AL | 1 |
| Rossouw, JE | 1 |
| Santanello, NC | 1 |
| Heyse, JF | 1 |
| Furberg, CD | 1 |
| Gaw, A | 1 |
| Packard, CJ | 2 |
| Caslake, MJ | 2 |
| Griffin, BA | 1 |
| Lindsay, GM | 1 |
| Thomson, J | 1 |
| Vallance, BD | 1 |
| Wosornu, D | 1 |
| Shepherd, J | 2 |
| Horwitz, RI | 1 |
| Horwitz, SM | 1 |
| Farmer, JA | 1 |
| Gotto, AM | 1 |
| Immich, H | 1 |
| Boumendil, EF | 1 |
| Schaefer, JR | 1 |
| Herzum, M | 1 |
| Maisch, B | 1 |
| Stein, EA | 1 |
| Pettifor, J | 1 |
| Mieny, C | 1 |
| Heimann, KW | 1 |
| Spitz, L | 1 |
| Saaron, I | 1 |
| Dinner, M | 1 |
| Carlson, LA | 4 |
| Olsson, AG | 4 |
| Ilyas, M | 1 |
| Peracha, MA | 1 |
| Ali, N | 1 |
| Husnain Sherazi, SM | 1 |
| Mahmood, N | 1 |
| Adam, O | 1 |
| Wolfram, G | 4 |
| Zöllner, N | 3 |
| McIntyre, N | 1 |
| Harry, DS | 1 |
| Pearson, AJ | 1 |
| Rider, AK | 1 |
| Jung, W | 1 |
| Kremer, GJ | 1 |
| Müller, D | 1 |
| Ritland, S | 1 |
| Fausa, O | 1 |
| Gjone, E | 1 |
| Blomhoff, JP | 1 |
| Skrede, S | 1 |
| Lanner, A | 2 |
| Orö, L | 3 |
| Rössner, S | 3 |
| Hedstrand, H | 1 |
| Ditzel, J | 1 |
| Bang, HO | 1 |
| Rouffy, J | 1 |
| Dreux, C | 1 |
| Goussault, Y | 1 |
| Dakkak, R | 1 |
| Renson, FJ | 1 |
| Gaertner, U | 1 |
| Johannes, KJ | 1 |
| Fisher, WR | 1 |
| Truitt, DH | 1 |
| Pichardo, R | 1 |
| Boulet, L | 1 |
| Hellström, K | 1 |
| Einarsson, K | 1 |
| Simons, LA | 2 |
| Hickie, JB | 1 |
| Ruys, J | 1 |
| Luepker, RV | 1 |
| Smith, LK | 1 |
| Rothchild, SS | 1 |
| Gillis, A | 1 |
| Kochman, L | 1 |
| Warbasse, JR | 1 |
| Müller, A | 1 |
| Klose, G | 1 |
| Augustin, J | 1 |
| Haase, W | 2 |
| Greten, H | 1 |
| Suermann, I | 3 |
| Göhmann, E | 2 |
| Colman, RW | 2 |
| Manninen, V | 1 |
| Mälkönen, M | 1 |
| Tuomilehto, J | 1 |
| Loewer, H | 1 |
| Schmidt, GG | 1 |
| Lehtonen, A | 2 |
| Viikari, J | 2 |
| Grundy, SM | 4 |
| Metelitsa, VI | 2 |
| Dokuchaeva, EA | 1 |
| Chubukova, AL | 1 |
| Iliushina, IP | 1 |
| Ostrovskaia, TP | 1 |
| Fellin, R | 2 |
| Baggio, G | 2 |
| Briani, G | 2 |
| Baiocchi, MR | 2 |
| Manzato, E | 1 |
| Baldo, G | 1 |
| Crepaldi, G | 2 |
| Heel, RC | 1 |
| Brogden, RN | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| de Gennes, JL | 2 |
| Howard, AN | 6 |
| Martz, BL | 1 |
| Fowler, PB | 2 |
| Kissebah, AH | 1 |
| Giuliani, A | 1 |
| Trezzini, C | 1 |
| Urbinati, G | 1 |
| Conti, R | 1 |
| Dimroth, H | 1 |
| Priego, JG | 1 |
| Maroto, ML | 1 |
| Piña, M | 1 |
| Catalán, RE | 1 |
| Bjerkelund, C | 1 |
| Erikssen, J | 1 |
| Thaulow, E | 1 |
| Kritchevsky, D | 2 |
| Roncari, DA | 1 |
| Anthony, LE | 1 |
| Schmucker, DL | 1 |
| Mooney, JS | 1 |
| Jones, AL | 1 |
| Vilageliu, J | 1 |
| Zapatero, MD | 1 |
| Bruseghini, L | 1 |
| Tomarelli, RM | 1 |
| Bauman, LM | 1 |
| Savini, S | 1 |
| Gibson, JC | 1 |
| Isbister, JP | 1 |
| Biggs, JC | 1 |
| Kuppurajan, K | 1 |
| Rajagopalan, SS | 1 |
| Rao, TK | 1 |
| Sitaraman, R | 1 |
| Ahrens, EH | 2 |
| Rahlfs, VW | 1 |
| Zimmermann, H | 1 |
| Safer, A | 1 |
| Keller, C | 2 |
| Younger, RK | 1 |
| Curtis, JJ | 1 |
| Butts, WH | 1 |
| Scott, HW | 1 |
| Mok, HY | 1 |
| Deckelbaum, RJ | 1 |
| Lees, RS | 4 |
| Small, DM | 1 |
| Hedberg, SE | 1 |
| Wallenstein, S | 1 |
| Fisher, AC | 1 |
| Delbarre, F | 1 |
| Rondier, J | 1 |
| de Géry, A | 1 |
| Albertini, F | 1 |
| Hull, L | 1 |
| Huttunen, J | 1 |
| Brunner, G | 1 |
| Lees, AM | 1 |
| Hayashi, E | 2 |
| Yamada, J | 1 |
| Kunitomo, M | 1 |
| Terada, M | 1 |
| Tomita, T | 2 |
| West, RJ | 1 |
| Fosbrooke, AS | 1 |
| Lloyd, JK | 1 |
| Kaffarnik, H | 3 |
| Schneider, J | 3 |
| Hankiewicz, J | 1 |
| Szeruda-Rudzka, E | 1 |
| Rowe, WS | 1 |
| Tierney, E | 1 |
| Kim, DN | 2 |
| Lee, KT | 2 |
| Reiner, JM | 2 |
| Thomas, WA | 2 |
| Summerfield, JA | 1 |
| Elias, E | 1 |
| Sherlock, S | 1 |
| Rossini, L | 1 |
| Norum, KR | 1 |
| Nestel, PJ | 3 |
| Kudchodkar, B | 1 |
| D'Alessandro, A | 1 |
| Zucconi, A | 1 |
| Bellini, F | 1 |
| Boncinelli, L | 1 |
| Chiostri, R | 1 |
| Tepper, SA | 1 |
| Story, JA | 1 |
| Kilani, S | 1 |
| Faergeman, AO | 1 |
| Bohmer, T | 1 |
| Godoy, JM | 1 |
| Nicaretta, DH | 1 |
| Balassiano, SL | 1 |
| Skacel, M | 1 |
| Heady, JA | 1 |
| Morris, JN | 1 |
| Hughes, MD | 1 |
| Pocock, SJ | 1 |
| Henry, DA | 1 |
| Cully, LR | 1 |
| Grigson, T | 1 |
| Lee, C | 1 |
| Dil'man, VM | 1 |
| Kovaleva, IG | 1 |
| Gavelli, MS | 1 |
| Vitaliano, E | 2 |
| Serra, T | 1 |
| Rossi, FG | 1 |
| Rizzuti, A | 1 |
| Caridis, R | 1 |
| Tozzi, J | 1 |
| Rywik, S | 1 |
| Nityanand, S | 1 |
| Srivastava, JS | 1 |
| Asthana, OP | 1 |
| Dembińska-Kieć, A | 1 |
| Kostka-Trabka, E | 1 |
| Grodzińska, L | 1 |
| Bieroń, K | 1 |
| Kedzior, A | 1 |
| Basista, M | 1 |
| Zmuda, A | 1 |
| Trabka, E | 1 |
| Slawiński, M | 1 |
| Czarnecka, H | 1 |
| Guarini, G | 1 |
| Costa, C | 1 |
| Trimarco, C | 1 |
| Santese, D | 1 |
| Kane, JP | 2 |
| Malloy, MJ | 1 |
| Series, JJ | 1 |
| Kilday, C | 1 |
| Cruickshank, A | 1 |
| Demant, T | 1 |
| Tikkanen, MJ | 1 |
| Nikkilä, EA | 1 |
| Havel, RJ | 1 |
| Schmidt, J | 1 |
| Severino, D | 1 |
| Stuyt, PM | 1 |
| Levy, RI | 2 |
| Simpson, IA | 1 |
| Lorimer, AR | 1 |
| Walker, ID | 1 |
| Davidson, JF | 1 |
| Sodhi, HS | 1 |
| Kudchodkar, BJ | 1 |
| Menotti, A | 1 |
| Puddu, V | 1 |
| Turpin, G | 1 |
| Truffert, J | 1 |
| Simane, Z | 1 |
| Nowak, H | 1 |
| Penttilä, IM | 1 |
| Lampainen, E | 1 |
| Yamamura, Y | 1 |
| Nagakura, T | 1 |
| von Löwis, P | 1 |
| Klemens, UH | 1 |
| Gustafson, A | 1 |
| Carvalho, AC | 1 |
| Albrink, MJ | 1 |
| Knüchel, F | 1 |
| Bybee, DE | 1 |
| Hamilton, RD | 1 |
| Emmrich, R | 1 |
| Ditschuneit, H | 1 |
| Frenk, E | 1 |
| Walker, AE | 1 |
| Edwards, IR | 1 |
| Braunsteiner, H | 1 |
| Sailer, S | 1 |
| Sandhofer, F | 1 |
| Edwards, KD | 1 |
| Berkowitz, D | 2 |
| Miller, NE | 1 |
| Clifton-Bligh, P | 1 |
| Whyte, HM | 1 |
| Dujovne, CA | 1 |
| Hurwitz, A | 1 |
| Kauffman, RE | 1 |
| Azarnoff, DL | 1 |
| Bagdade, JD | 1 |
| Fourrier, A | 1 |
| Mouton, Y | 1 |
| Strasek, J | 1 |
| Evans, RJ | 2 |
| Hyams, DE | 4 |
| Schlierf, G | 1 |
| Cloarec, M | 2 |
| Page, W | 1 |
| Vanderveiken, F | 1 |
| Van Melsen, A | 1 |
| Van Melsen, Y | 1 |
| Baldoni, F | 1 |
| Egge, H | 1 |
| Giarola, P | 1 |
| Müller, H | 1 |
| Cuttin, S | 1 |
| Gibelli, A | 1 |
| Zilliken, F | 1 |
| de Nicola, P | 1 |
| Evans, C | 1 |
| Oye, I | 2 |
| Paoletti, R | 1 |
| Fumagalli, R | 1 |
| Sirtori, R | 1 |
| Brownstein, S | 1 |
| Font, RL | 1 |
| Alper, MG | 1 |
| Bavina, MV | 1 |
| Perova, NV | 1 |
| Lobova, NM | 1 |
| Koropova, GI | 1 |
| Faergeman, O | 1 |
| Warembourg, H | 1 |
| Jaillard, J | 1 |
| Fenderson, RW | 1 |
| Sekowski, I | 1 |
| Mohan, C | 1 |
| Deutsch, S | 1 |
| Benjamin, F | 1 |
| Samuel, P | 1 |
| Seifert, A | 1 |
| Parker, F | 1 |
| Short, JM | 1 |
| Wilson, DE | 1 |
| Langer, T | 1 |
| Mitchell, WD | 1 |
| Murchison, LE | 1 |
| Likoff, W | 1 |
| Salen, G | 1 |
| Schreibman, PH | 1 |
| Spector, AA | 1 |
| Anet, P | 1 |
| Brouns, H | 1 |
| Delescluse, A | 1 |
| Malcolm, J | 1 |
| Van den Abbeele, KG | 1 |
| Kannel, WB | 1 |
| Garcia, MJ | 1 |
| McNamara, PM | 1 |
| Pearson, G | 1 |
| Fasoli, A | 1 |
| Cotton, RC | 1 |
| Lewis, B | 1 |
| Manaresi, A | 1 |
| Dal Monte, PR | 1 |
| Menghi, B | 1 |
| Cremonini, R | 1 |
| Sarti, F | 1 |
| Toscano, S | 1 |
| Myant, NB | 1 |
| Heffernan, A | 1 |
| Hickey, N | 1 |
| Mulcahy, R | 1 |
| Fitzgerald, O | 1 |
| Bronzini, A | 1 |
| Di Gregorio, D | 1 |
| Scotti, G | 1 |
| Pometta, D | 1 |
| el-Mehairy, MM | 1 |
| Attia, O | 1 |
| Nabih, AE | 1 |
| Nassar, I | 1 |
| Ibrahim, WN | 1 |
| Duncan, CH | 1 |
| Best, MM | 1 |
| Kaunitz, H | 1 |
| Sharland, DE | 1 |
| Grafnetter, D | 1 |
| Mrhová, O | 1 |
| Janda, J | 1 |
| Aubry, F | 1 |
| Lapierre, YL | 1 |
| Noël, C | 1 |
| Matova, EE | 1 |
| Aptekar', SG | 1 |
| Maha, GE | 1 |
| Sugar, M | 1 |
| Bassett, DR | 1 |
| Bookstein, JJ | 1 |
| Hough, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy: A Randomized, Multicenter, Multinational Study[NCT01291641] | Phase 4 | 342 participants (Actual) | Interventional | 2011-03-31 | Completed | ||
| Development and Evaluation of a Therapeutic Education Intervention Focused on the Accession of Patients Treated With Hormonal Therapy in the Management of Breast Cancer: PEPs Hormonotherapy[NCT02300675] | 352 participants (Actual) | Interventional | 2014-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
30 reviews available for clofibrate and Hypercholesterolemia
| Article | Year |
|---|---|
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; H | 2003 |
[Pharmacology of probucol. I].
Topics: Adult; Aged; Animals; Anticholesteremic Agents; Chemical Phenomena; Chemistry; Cholesterol; Clofibra | 1984 |
Effects of hypolipidemic drugs on bile acid metabolism in man.
Topics: Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fiber; Feces; Hum | 1981 |
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis.
Topics: Cholesterol; Clofibrate; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperl | 1984 |
Cholesterol reduction yields clinical benefit. A new look at old data.
Topics: Cholesterol; Cholesterol, Dietary; Clofibrate; Coronary Disease; Dextrothyroxine; Estrogens; Gemfibr | 1995 |
Adherence to treatment and health outcomes.
Topics: Clofibrate; Double-Blind Method; Evaluation Studies as Topic; Humans; Hypercholesterolemia; Male; My | 1993 |
Choosing the right lipid-regulating agent. A guide to selection.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrat | 1996 |
[Prevention of coronary heart disease--"evidence-based medicine" of antilipemic therapy].
Topics: Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Coronary Artery Disease; Evidence-Ba | 1999 |
The hypercholesterolaemia of obstructive jaundice.
Topics: Animals; Bile Ducts; Cholestasis; Cholesterol; Cholestyramine Resin; Clofibrate; Electrophoresis, Po | 1975 |
The common hyperlipoproteinemias: an understanding of disease mechanisms and their control.
Topics: Cholestyramine Resin; Clofibrate; Estrogens; Ethanol; Humans; Hypercholesterolemia; Hyperlipidemias; | 1976 |
Bile acid metabolism in hyperlipoproteinaemia.
Topics: Bile Acids and Salts; Cholelithiasis; Cholesterol; Cholestyramine Resin; Cholic Acids; Chylomicrons; | 1977 |
Treatment of hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Cole | 1977 |
Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.
Topics: Animals; Arteriosclerosis; Clofibrate; Dogs; Humans; Hypercholesterolemia; Hyperlipidemias; Kinetics | 1978 |
The management of hyperlipidemia: whether, rather than how.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dietary Fats; Drug Evaluation; | 1976 |
Hypolipaemic drugs and coronary heart disease.
Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Dise | 1975 |
[Hypercholesteremia].
Topics: Age Factors; Aged; Cholagogues and Choleretics; Cholesterol; Circadian Rhythm; Clofibrate; Depressio | 1975 |
When to treat hyperlipidemia.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; H | 1988 |
Treatment of hypercholesterolemia.
Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; | 1986 |
Dietary and drug treatment of primary hyperlipoproteinemia.
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; | 1972 |
Dietary and drug treatment of hyperlipidemia in diabetes.
Topics: Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholestyramine Resin; Clofibrate; Diabetes M | 1974 |
The primary hyperlipoproteinemias.
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Humans; Hyperc | 1974 |
Therapeutics XIX. Lipid lowering agents.
Topics: Animals; Arteriosclerosis; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Coronary Disea | 1972 |
[Clinical aspects and therapy of primary hyperlipemias].
Topics: Aged; Chylomicrons; Clofibrate; Dietary Fats; Humans; Hypercholesterolemia; Hyperlipidemias; Lipopro | 1972 |
Antilipaemic drugs and nephrotic hyperlipidaemia.
Topics: Alkenes; Animals; Blood Protein Disorders; Blood Proteins; Butyrates; Clofibrate; Humans; Hyperchole | 1972 |
Management of the hyperlipidemic patient.
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrothy | 1973 |
Therapy of the hyperlipoproteinemias.
Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; Hyper | 1972 |
[The treatment of essential hyperlipidemia with clofibrate].
Topics: Anticholesteremic Agents; Blood Protein Electrophoresis; Cholesterol; Clofibrate; Diabetic Angiopath | 1969 |
Xanthomatosis associated with hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Chylomicrons; Clofibrate; D | 1970 |
The treatment of hyperlipidemia.
Topics: Bile Acids and Salts; Cholesterol; Chylomicrons; Clofibrate; Dextrothyroxine; Diet Therapy; Fasting; | 1971 |
Hypolipidemic drugs and hyperlipoproteinemia.
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperc | 1971 |
48 trials available for clofibrate and Hypercholesterolemia
| Article | Year |
|---|---|
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; D | 1983 |
[Study of the antilipemic effect of etofibrate (Lipo-Merz)].
Topics: Adult; Aged; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Female; | 1983 |
Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Colestipol; Female; Humans; Hypercholesterolemia; | 1981 |
Effects of ciprofibrate on LDL metabolism in man.
Topics: Adult; Aged; Apolipoproteins; Clofibrate; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins | 1994 |
Clofibrate: a final verdict?
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Drug Evaluation; Humans; | 1978 |
Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Hypercholesterol | 1979 |
Effects of clofibrate in hyperlipidemia: a controlled trial.
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipide | 1978 |
[Dose-effects studies with bezafibrate in patients with hypercholesterolemia and hypertriglyceridemia (author's transl)].
Topics: Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hypercho | 1979 |
Effect of treatment with a bile-sequestering agent (Secholex) on intestinal absorption, duodenal bile acids, and plasma lipids.
Topics: Adolescent; Adult; Anion Exchange Resins; Bile Acids and Salts; Blood Glucose; Cholesterol; Clinical | 1975 |
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Drug Therapy, Combination; Humans; Hyper | 1975 |
Clofibrate in type II hyperlipoproteinemia.
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Female; Humans; Hypercholesterol | 1976 |
Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
Topics: Clinical Trials as Topic; Clofibrate; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperli | 1976 |
[Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
Topics: Adult; Aged; Cholesterol; Chylomicrons; Clofibrate; Drug Combinations; Female; Glycerylphosphorylcho | 1976 |
Management of hypercholesterolemia: evaluation of practical clinical approaches in healthy young adults.
Topics: Adult; Body Weight; Cholesterol; Clofibrate; Dietary Fats; Female; Humans; Hypercholesterolemia; Lip | 1978 |
[Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
Topics: Adolescent; Adult; Aged; Cholesterol; Clofibrate; Drug Combinations; Female; Humans; Hypercholestero | 1978 |
Long-term effect of the combination of calcium clofibrate and calcium carbonate on serum total cholesterol, triglyceride and high density lipoprotein--cholesterol concentrations in hyperlipoproteinaemia. A comparative study with clofibrate.
Topics: Adult; Calcium Carbonate; Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Li | 1979 |
Effect of clofibrate and calcium in type II A hyperlipoproteinaemia.
Topics: Calcium; Calcium Carbonate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Drug Evaluat | 1977 |
[3-year treatment of hypercholesteremia with clofibrate under conditions of double-blind method].
Topics: Adult; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Drug Evaluation; Follow-Up Studies | 1978 |
Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Colestipol; Drug Therapy, Combination; Fem | 1978 |
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
Topics: Adult; Cardiovascular Diseases; Cholelithiasis; Cholesterol; Clinical Trials as Topic; Clofibrate; C | 1978 |
[Real or alleged risks of clofibrate derivatives and certain risks of their prohibition].
Topics: Adult; Arteriosclerosis; Cholelithiasis; Clinical Trials as Topic; Clofibrate; Coronary Disease; Eur | 1979 |
The clofibrate trial--the lipid hypothesis retested.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Double-Blind Method; Humans; Hy | 1979 |
The management of hyperlipidemia: whether, rather than how.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dietary Fats; Drug Evaluation; | 1976 |
Hypolipaemic drugs and coronary heart disease.
Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Dise | 1975 |
[Etofibrate and clofibrate in double blind study].
Topics: Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Humans; Hypercholest | 1976 |
[Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
Topics: Chemical Phenomena; Chemistry; Clinical Trials as Topic; Clofibrate; Humans; Hypercholesterolemia; H | 1975 |
[Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
Topics: Cholesterol; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; N | 1976 |
WHO clofibrate/cholesterol trial: clarifications.
Topics: Clofibrate; Humans; Hypercholesterolemia; Male; Meta-Analysis as Topic; Myocardial Ischemia; Researc | 1992 |
Within-subject diastolic blood pressure variability: implications for risk assessment and screening.
Topics: Adult; Age Factors; Analysis of Variance; Bayes Theorem; Blood Pressure; Cardiovascular Diseases; Ch | 1992 |
[Control of the effectiveness of the hypolipidemic effects of miscleron and phenformin].
Topics: Anticholesteremic Agents; Blood Platelets; Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Ly | 1991 |
[Comparison of the lowering effect on blood cholesterol of clofibrate and simvastatin].
Topics: Aged; Anticholesteremic Agents; Clofibrate; Drug Evaluation; Female; Humans; Hypercholesterolemia; L | 1990 |
[Is hypolipemic treatment effective as a preventive measure?].
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Clofibrat | 1989 |
Clinical trials with gugulipid. A new hypolipidaemic agent.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Commiphora; Double-Blind Method; Female; H | 1989 |
[Effects on lipid metabolism of inhibitors of cholesterol synthesis].
Topics: Aged; Anticholesteremic Agents; Cholesterol; Clinical Trials as Topic; Clofibrate; Double-Blind Meth | 1988 |
Prevention of coronary heart disease--propaganda, promises, problems, and prospects.
Topics: Adult; Arteriosclerosis; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diet; | 1986 |
Primary prevention of coronary heart disease by lowering lipids: results and implications.
Topics: Cholesterol, LDL; Clinical Trials as Topic; Clofibrate; Coronary Artery Bypass; Coronary Disease; Di | 1985 |
[Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)].
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Ambulatory Care; Anticoagulants; Aspartate | 1973 |
Treatment of hyperlipoproteinaemia type II A with a new anion exchange resin secholex.
Topics: Adult; Clinical Trials as Topic; Clofibrate; Dextrans; Diethylamines; Female; Humans; Hypercholester | 1974 |
[Effect of a new lipid-reducing preparation (Etofibrat) on hyperlipoproteinemia type II. 2].
Topics: Clinical Trials as Topic; Clofibrate; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; | 1974 |
Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
Topics: Adult; Alkaline Phosphatase; Anticholesteremic Agents; Blood Glucose; Calcium; Cholesterol; Clinical | 1973 |
Colestipol and clofibrate in hypercholesterolemia.
Topics: Adult; Aged; Alkaline Phosphatase; Analysis of Variance; Anticholesteremic Agents; Blood Pressure; B | 1974 |
[Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Diet; Drug The | 1974 |
[Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Diet, Reducing; Drug Tolerance; Female; Humans; H | 1974 |
Clofibrate for prevention of myocardial infarction.
Topics: Angina Pectoris; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Hypercholesterolemi | 1973 |
Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycin.
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Clofibrate; Constipation; Depression, Chemical; Diar | 1973 |
Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia.
Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; C | 1971 |
[Effect of a new drug association on hypercholesteremia studied with a controlled clinical trial].
Topics: Adult; Aged; Amino Alcohols; Anticholesteremic Agents; Clofibrate; Female; Humans; Hypercholesterole | 1971 |
Effects of a phenolic ether, Su-13437, on serum cholesterol, triglyceride, and transaminase levels of human subjects.
Topics: Adult; Aged; Alanine Transaminase; Anticholesteremic Agents; Aspartate Aminotransferases; Body Weigh | 1970 |
171 other studies available for clofibrate and Hypercholesterolemia
| Article | Year |
|---|---|
Potential hypolipidemic agents derived from 3-hydroxy-17,17-dimethylgona-1,3,5(10),8,11,13-hexaene.
Topics: Animals; Cholesterol; Clofibrate; Female; Gonanes; Hypercholesterolemia; Hypolipidemic Agents; Male; | 1977 |
Hypolipidemic 2-[4-(1,1-dimethylethyl)phenyl]-4H-3,1-benzoxazin-4-ones. Structure-activity relationships of a novel series of high-density lipoprotein elevators.
Topics: Animals; Chemical Phenomena; Chemistry; Cholesterol; Cholesterol, HDL; Hypercholesterolemia; Hypolip | 1989 |
N-imidazolylchroman-4-ones, N-imidazolyl-1-tetralones, and their alcohols as hypolipemic agents raising high-density lipoproteins.
Topics: Alcohols; Animals; Cholesterol; Enzyme Induction; Hypercholesterolemia; Hypolipidemic Agents; Imidaz | 1986 |
Cholesterol-lowering and cancer in the prevention of cardiovascular disease.
Topics: Cardiovascular Diseases; Clofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperch | 2010 |
Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.
Topics: Androsterone; Anticoagulants; Butyrates; Clofibrate; Coronary Disease; Hypercholesterolemia; Hyperli | 1963 |
Effect of atromid on anticoagulant requirements.
Topics: Anticoagulants; Clofibrate; Hypercholesterolemia; Phenindione | 1963 |
Atromid, phenindione, and blood coagulation.
Topics: Blood Coagulation; Clofibrate; Hypercholesterolemia; Phenindione | 1963 |
AGRANULOCYTOSIS DURING ADMINISTRATION OF "ATROMID".
Topics: Agranulocytosis; Androsterone; Butyrates; Clofibrate; Hypercholesterolemia; Phenindione; Toxicology | 1963 |
THE EFFECT OF ATROMID, AN ORALLY ACTIVE ANDROSTERONE ON SERUM LIPIDS IN NORMAL, HYPERCHOLESTEROLAEMIC AND HYPERLIPAEMIC SUBJECTS.
Topics: Androsterone; Aspartate Aminotransferases; Cholesterol; Clofibrate; Glycerides; Humans; Hypercholest | 1963 |
THE TREATMENT OF XANTHOMATOSIS WITH ATROMID.
Topics: Androsterone; Blood Chemical Analysis; Butyrates; Clofibrate; Hypercholesterolemia; Hyperlipidemias; | 1964 |
THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.
Topics: Androsterone; Biomedical Research; Blood Chemical Analysis; Blood Proteins; Body Weight; Butyrates; | 1964 |
[ATROMID IN HYPERCHOLESTEROLEMIA AND HYPERLIPEMIA. LITERATURE REVIEW AND RESULTS OF CLINICAL TESTS].
Topics: Androsterone; Biomedical Research; Butyrates; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidem | 1964 |
"ATROMID" IN ATHEROSCLEROSIS.
Topics: Androsterone; Angina Pectoris; Arteriosclerosis Obliterans; Atherosclerosis; Blood Chemical Analysis | 1964 |
[THE ACTION OF CLOFIBRATE-ANDROSTERONE ON THE PLASMA CHOLESTEROL AND LIPIDS].
Topics: Androsterone; Butyrates; Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Lip | 1964 |
EFFECT OF CLOFIBRATE AND ANDROSTERONE ON HYPERCHOLESTEROLAEMIC XANTHOMATOSIS.
Topics: Androsterone; Butyrates; Clofibrate; Hypercholesterolemia; Pharmacology; Xanthomatosis | 1965 |
THE TREATMENT OF XANTHOMATOSIS WITH "ATROMID".
Topics: Androsterone; Blood Chemical Analysis; Butyrates; Clofibrate; Drug Therapy; Hypercholesterolemia; Hy | 1964 |
[EFFECT OF DEHYDROEPIANDROSTERONE AND ATROMID ON SERUM LIPIDS IN PATIENTS WITH HYPERCHOLESTEREMIA OR HYPERTRIGLYCERIDEMIA].
Topics: Androsterone; Butyrates; Clofibrate; Dehydroepiandrosterone; Humans; Hypercholesterolemia; Hyperlipi | 1965 |
[CLINICAL STUDIES ON ATROMID. I. EFFECT OF ATROMID ON BLOOD SERUM LIPIDS AND LIVER FUNCTION TESTS].
Topics: Androsterone; Anticholesteremic Agents; Biomedical Research; Clofibrate; Humans; Hypercholesterolemi | 1964 |
[CLINICAL STUDIES ON ATROMID. II. EFFECT OF ATROMID ON BLOOD COAGULATION AND FIBRINOLYSIS].
Topics: Androsterone; Anticholesteremic Agents; Biomedical Research; Blood Coagulation; Clofibrate; Fibrinol | 1964 |
[STEROID EXCRETION AFTER ATROMID AND DEHYDROEPIANDROSTERONE IN PERSONS WITH HYPERCHOLESTEREMIA].
Topics: Clofibrate; Dehydroepiandrosterone; Drug Therapy; Humans; Hypercholesterolemia | 1965 |
THE EFFECT OF ATROMID AND ATROMID-S ON PLASMA FIBRINOGEN AND PLASMINOGEN LEVELS.
Topics: Androsterone; Anticholesteremic Agents; Biomedical Research; Butyrates; Clofibrate; Coronary Disease | 1965 |
A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.
Topics: Androsterone; Anticholesteremic Agents; Butyrates; Clofibrate; Coronary Disease; Drug Therapy; Elect | 1965 |
Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
Topics: Alanine Transaminase; Animals; Anticholesteremic Agents; Aspartate Aminotransferases; Aspartic Acid; | 2005 |
The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats.
Topics: Animals; Blood Glucose; Cholesterol; Cholesterol, Dietary; Clofibrate; Diabetes Mellitus, Experiment | 2005 |
Protective effect of simvastatin and VULM 1457 in ischaemic-reperfused myocardium of the diabetic-hypercholesterolemic rats.
Topics: Animals; Arrhythmias, Cardiac; Blood Glucose; Cholesterol; Cholesterol, Dietary; Clofibrate; Diabete | 2006 |
The myocardial infarct size-limiting and antiarrhythmic effects of acyl-CoA:cholesterol acyltransferase inhibitor VULM 1457 protect the hearts of diabetic-hypercholesterolaemic rats against ischaemia/reperfusion injury both in vitro and in vivo.
Topics: Animals; Anti-Arrhythmia Agents; Cholesterol, Dietary; Clofibrate; Diabetes Mellitus, Experimental; | 2007 |
The clofibrate problem.
Topics: Clofibrate; Coronary Disease; Humans; Hypercholesterolemia; Male | 1980 |
[Potentiation by clofibride of the heparin-induced clearing reaction (intravascular hydrolysis of neutral lipids), in hyperlipemic rabbits].
Topics: Animals; Cholesterol; Clofibrate; Drug Synergism; Fatty Acids, Nonesterified; Female; Heparin; Hyper | 1982 |
Adenoma with multiple hyperplastic nodules in noncirrhotic liver possibly related to long-term administration of a hypolipidemic drug.
Topics: Aged; Carcinoma, Hepatocellular; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperplasia; Hype | 1982 |
Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats.
Topics: Acetates; Animals; Cholesterol; Clofibrate; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins | 1984 |
Experimental atherosclerosis in hypercholesterolemic mini-pigs. Regression of cholesterol ester accumulation in aorta and coronary arteries after treatment with clofibrate, beta-pyridylcarbinol or a normo-lipidemic diet.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol | 1982 |
Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrate.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins; Apolipoproteins B; Bezafibrat | 1981 |
Hypercholesterolemia in ExHC rats and lipid-lowering drug: a screening method for new hypocholesterolemic agents.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins; Cholesterol; Clofibrate; Dru | 1981 |
How vitamin C, clofibrate and diosgenin control cholesterol metabolism in male guinea-pigs.
Topics: Animals; Ascorbic Acid; Cholesterol; Clofibrate; Diet; Diosgenin; Growth; Guinea Pigs; Hypercholeste | 1982 |
Workshop on the role of vitamin C in lipid metabolism.
Topics: Animals; Arteriosclerosis; Ascorbic Acid; Clofibrate; Diet; Drug Interactions; Humans; Hypercholeste | 1982 |
Serious adverse effects with clofibrate.
Topics: Clofibrate; Coronary Disease; Humans; Hypercholesterolemia; Male; United Kingdom | 1980 |
Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Dose-Respon | 1981 |
Clofibrate and eosinophilic pneumonia.
Topics: Aged; Clofibrate; Humans; Hypercholesterolemia; Male; Pulmonary Eosinophilia | 1982 |
Experience with probucol in the treatment of hypercholesterolemia.
Topics: Cholesterol; Clofibrate; Clofibric Acid; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Ag | 1982 |
[Current treatment with clofibrate or clofibric acid (Regadrin)].
Topics: Cholelithiasis; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hypercholesterolemia; Hyperlipoprot | 1982 |
Bezafibrate treatment in primary hypercholesterolaemia. Possibility of intermittent treatment.
Topics: Animals; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Clofibric Acid; H | 1982 |
[Comparative effect of probucol and clofibrate in patients with primary hypercholesterolemia].
Topics: Adult; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle | 1982 |
[Study of clofibrate. The opinion of Prof. D. Kritchevsky].
Topics: Adult; Arteriosclerosis; Cholelithiasis; Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hype | 1980 |
[Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate].
Topics: Adult; Bezafibrate; Clofibrate; Clofibric Acid; Drug Administration Schedule; Female; Humans; Hyperc | 1980 |
Choice of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Huma | 1993 |
[Cholesterol and coronary sclerosis].
Topics: Anticholesteremic Agents; Cholesterol; Clofibrate; Coronary Artery Disease; Humans; Hypercholesterol | 1997 |
Mortality from non-cardiovascular disease and diabetes mellitus.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cause of Death; Clofibrate; Diabetes Mellitus; Fr | 1998 |
Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
Topics: Anticholesteremic Agents; Bezafibrate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; F | 1999 |
Portacaval shunt in four patients with homozygous hypercholesterolaemia.
Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fats; Female; Gluco | 1975 |
Serum-lipoproteins and the W.H.O. clofibrate trial.
Topics: Clofibrate; Humans; Hypercholesterolemia; Lipoproteins, HDL; Male | 1979 |
Should hyperlipoproteinemia be treated in patients with coronary artery disease?
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Body Weight; Cholestyramine Resin; Clofibrate; Coronary D | 1975 |
[Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
Topics: Adult; Age Factors; Aged; Chylomicrons; Clofibrate; Diabetes Complications; Drug Therapy, Combinatio | 1975 |
Dietary and drug treatment of hyperlipidaemia. A feasibility study in asymptomatic middle-aged men.
Topics: Body Weight; Cholesterol; Clofibrate; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperlipidemi | 1976 |
Pharmacokinetics of clofibrate in familial hypercholesterolemia.
Topics: Adolescent; Adult; Body Weight; Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Drug Resi | 1977 |
Treatment of hypercholesterolaemia with oral lecithin.
Topics: Adult; Cholesterol; Clofibrate; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lip | 1977 |
[Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)].
Topics: Adult; Aged; Apolipoproteins; Cholesterol; Clofibrate; Female; Humans; Hypercholesterolemia; Lipopro | 1978 |
Platelet function in thrombosis and atherosclerosis.
Topics: Adenylyl Cyclases; Arteriosclerosis; Blood Platelets; Cell Membrane; Clofibrate; Cyclic AMP; Halofen | 1978 |
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Topics: Cholestyramine Resin; Clofibrate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Human | 1975 |
[Influence of "prudent" diet and clofibrate upon apolipoprotein B in hyperlipoproteinemia type IIa (author's transl)].
Topics: Aged; Apolipoproteins; Clofibrate; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Mi | 1979 |
Treating lipid disorders.
Topics: Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hypercholesterolemia; Hyperlipidemias; Hypoli | 1979 |
[Hyperlipoproteinemia type IIa. Serum lipoprotein pattern as influenced by diet and clofibrate].
Topics: Adult; Aged; Clofibrate; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; | 1979 |
The baboon as an experimental model in drug testing.
Topics: Animals; Antigen-Antibody Reactions; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyra | 1977 |
Drug management of hypercholesterolemia.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hypercholesterolemia; Nicotin | 1979 |
Clofibrate.
Topics: Clofibrate; Humans; Hypercholesterolemia; Thyroiditis | 1979 |
Management of hyperlipidemia in diabetes.
Topics: Cholestyramine Resin; Clofibrate; Diabetes Complications; Diabetes Mellitus, Type 1; Humans; Hyperch | 1979 |
[Use of symfibrate in the treatment of hyperlipemias. Preliminary data].
Topics: Administration, Oral; Adult; Cholesterol; Clofibrate; Drug Evaluation; Humans; Hypercholesterolemia; | 1979 |
[The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
Topics: Aged; Cholesterol; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle A | 1979 |
Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats.
Topics: Animals; Clofibrate; Clofibric Acid; Diet; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; | 1979 |
[Clofibrate in the primary prevention of coronary disease].
Topics: Clofibrate; Coronary Disease; Humans; Hypercholesterolemia | 1979 |
[The effect of clofibrate in the light of recent literature].
Topics: Animals; Clofibrate; Humans; Hypercholesterolemia | 1979 |
[The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini].
Topics: Arteriosclerosis; Clofibrate; Coronary Disease; Humans; Hypercholesterolemia; Hyperlipidemias; Myoca | 1979 |
A practical guide to hyperlipidaemic disorders.
Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids | 1977 |
Clofibrate and gallbladder disease.
Topics: Clofibrate; Gallbladder Diseases; Humans; Hypercholesterolemia | 1978 |
A quantitative analysis of fine structure and drug metabolism in livers of clofibrate-treated young adult and retired breeder rats.
Topics: Aging; Animals; Clofibrate; Cytochromes; Hypercholesterolemia; Lipid Metabolism; Liver; Male; Micros | 1978 |
Coronary Drug Project report on clofibrate and niacin.
Topics: Clofibrate; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Nicotinic Acids | 1978 |
[Hypolipemic activity of ITA 104].
Topics: Animals; Clofibrate; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Mice; Rats | 1978 |
Effect of Wy-14,643 on cholesterol metabolism in normal and hypercholesterolemic rats.
Topics: Animals; Cholesterol; Clofibrate; Feces; Hypercholesterolemia; Hypertrophy; Hypolipidemic Agents; Li | 1978 |
The effects of plasma exchange on cholesterol metabolism.
Topics: Adult; Cholesterol; Clofibrate; Evaluation Studies as Topic; Exchange Transfusion, Whole Blood; Fema | 1978 |
Effect of guggulu (Commiphora mukul--Engl.) on serum lipids in obese, hypercholesterolemic and hyperlipemic cases.
Topics: Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Obesity; Plant Extr | 1978 |
[Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
Topics: Angina Pectoris; Cerebrovascular Disorders; Cholesterol; Clofibrate; Delayed-Action Preparations; Fo | 1976 |
Protective effects of ileal bypass versus administration of clofibrate on experimental hypercholesterolemia and atherosclerosis in monkeys.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Clofibrate; Diet, Atherogenic; Disease | 1976 |
Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Topics: Adult; Bile; Bile Acids and Salts; Cholesterol; Clofibrate; Colestipol; Drug Therapy, Combination; F | 1977 |
Failure of complete bile diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia.
Topics: Administration, Oral; Adult; Bile; Bile Acids and Salts; Child; Cholecystectomy; Cholesterol; Cholic | 1977 |
The analysis of the two-period repeated measurements crossover design with application to clinical trials.
Topics: Analysis of Variance; Clofibrate; Colestipol; Griseofulvin; Humans; Hypercholesterolemia; Male; Rese | 1977 |
Lack of effect of two pectins in idiopathic or gout-associated hyperdyslipidemia hypercholesterolemia.
Topics: Citrus; Clofibrate; Fruit; Gout; Hypercholesterolemia; Hyperlipidemias; Lipids; Pectins; Structure-A | 1977 |
[Tinnitus and lipid metabolism disorders. Value of early normolipemic treatment].
Topics: Anticholesteremic Agents; Blood Platelet Disorders; Cholestyramine Resin; Clofibrate; Humans; Hyperc | 1977 |
Results of treatment of hyperlipidemias; short term effect on cholesterol metabolism.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Cholesterol; Clofibrate; Diet, Reducing; Female; Humans | 1977 |
Dextrothyroxine for lowering cholesterol.
Topics: Angina Pectoris; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Humans; Hypercholesterolemia; Hy | 1976 |
[Treatment of hyperlipidemia].
Topics: Adult; Cholestyramine Resin; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male | 1976 |
[Therapy of the chronic destructive, non-purulent cholangitis (primary biliary cirrhosis)].
Topics: Azathioprine; Calcium; Cholangitis; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; | 1976 |
Therapy of the hyperlipidemias.
Topics: Anticoagulants; Blood Platelets; Child; Cholesterol; Chylomicrons; Clofibrate; Diet, Reducing; Drug | 1976 |
Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. I. On the hypolipidemic effects.
Topics: Animals; Anticholesteremic Agents; Ascorbic Acid; Cholesterol; Clofibrate; Dose-Response Relationshi | 1976 |
Treatment of children with familial hypercholesterolaemia.
Topics: Adolescent; Celiac Disease; Child; Child, Preschool; Cholestyramine Resin; Clofibrate; Fatty Acids, | 1975 |
Some aspects of the management of the hyperlipidaemias.
Topics: Anion Exchange Resins; Clofibrate; Fats, Unsaturated; Humans; Hypercholesterolemia; Hyperlipidemias; | 1975 |
The investigation and treatment of hyperlipidaemia in general practice.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Reducing; Family Pract | 1975 |
Effect of combined clofibrate-cholestyramine treatment on serum and tissue cholesterol pools and on cholesterol synthesis in hypercholesterolemic swine.
Topics: Animals; Bile; Body Composition; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate | 1975 |
Effects of clofibrate in primary biliary cirrhosis hypercholesterolemia and gallstones.
Topics: Chenodeoxycholic Acid; Cholelithiasis; Clofibrate; Female; Humans; Hypercholesterolemia; Liver Cirrh | 1975 |
[Mechanism of action of drugs affecting lipid metabolism].
Topics: Animals; Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; H | 1975 |
[Treatment of hypercholesteremia].
Topics: Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Resins, Pla | 1975 |
Plasma squalene as an index of cholesterol synthesis.
Topics: Adult; Cholesterol; Cholesterol, Dietary; Clofibrate; Colestipol; Humans; Hypercholesterolemia; Hype | 1975 |
Lecithin:cholesterol acyltransferase activity in hypercholesterolemic subjects and in hypercholesterolemic subjects treated with clofibrate.
Topics: Acyltransferases; Adult; Age Factors; Aged; Cholesterol; Cholesterol Esters; Clofibrate; Female; Hum | 1975 |
Influence of an eggplant (Solanum melongena) preparation on cholesterol metabolism in rats).
Topics: Animals; Arteriosclerosis; Binding Sites; Cholesterol; Clofibrate; Hypercholesterolemia; Plant Extra | 1975 |
[Indications for lipid reducing drugs].
Topics: Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Triglycerides | 1976 |
[Letter: Treatment in hypercholestermia].
Topics: Adult; Body Weight; Clofibrate; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Smoking | 1976 |
[Iatrogeny. The importance of clinical diagnosis. Myopathies induced by clofibrate].
Topics: Aged; Clofibrate; Female; Humans; Hypercholesterolemia; Iatrogenic Disease; Myositis | 1992 |
Recent trends in the prescribing of cholesterol lowering drugs in Australia. A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee.
Topics: Aged; Anticholesteremic Agents; Australia; Clofibrate; Drug Prescriptions; Drug Utilization; Humans; | 1991 |
[Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].
Topics: Adult; Arteriosclerosis Obliterans; Cholesterol, HDL; Clofibrate; Clofibric Acid; Female; Humans; Hy | 1989 |
Influence of etofibrate on low density lipoprotein metabolism.
Topics: Adult; Anticholesteremic Agents; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; L | 1988 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Co | 1987 |
Influence of clofibrate on the plasma lipoprotein pattern and on the lipid content and protein and collagen synthesis in atherosclerotic coronary arteries and abdominal aorta from hypercholesterolemic mini-pigs.
Topics: Animals; Aorta, Abdominal; Arteriosclerosis; Clofibrate; Collagen; Coronary Artery Disease; Coronary | 1987 |
[Risks and benefits of a treatment: as exemplified by clofibrate].
Topics: Clofibrate; Humans; Hypercholesterolemia; Lipid Metabolism; Myocardial Infarction; Risk | 1987 |
Ethyl 2-([5,6-dihydro-7-(1H-imidazol-1-yl)-2-naphthalenyl]oxy)- 2-methylpropanoate as a new potent oxyisobutyrate hypolipidaemic with unusual features.
Topics: Animals; Bezafibrate; Chemical Phenomena; Chemistry; Cholesterol; Clofibrate; Diet; Hypercholesterol | 1987 |
[Drugs in hyperlipidemia].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemi | 1987 |
Effect of Ciprofibrate on platelet aggregation and fibrinolysis in patients with hypercholesterolaemia.
Topics: Adult; Alkaline Phosphatase; Cholesterol; Clofibrate; Clofibric Acid; Fibric Acids; Fibrinogen; Fibr | 1985 |
Correlating metabolism of plasma and tissue cholesterol with that of plasma-lipoproteins.
Topics: Animals; Bile; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Chylomicrons; Clofibrate; Fe | 1973 |
[Short-term pilot study of the feasibility of multifactor reduction of coronary risk].
Topics: Adult; Arteriosclerosis; Clofibrate; Clopamide; Coronary Disease; Diet Therapy; Dietary Fats; Ergolo | 1973 |
[Therapeutic correction of hereditary idiopathic hyperlipemia. Evaluation of a standard diet].
Topics: Clofibrate; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Long-Term Care; Methods | 1973 |
Proceedings: Potentiating of lipid lowering activity of clofibrate by combining with low doses of 3-pyridylcarbinol in rats.
Topics: Animals; Cholesterol; Clofibrate; Diet; Drug Synergism; Hypercholesterolemia; Hypolipidemic Agents; | 1974 |
Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
Topics: Adult; Blood Protein Electrophoresis; Cholesterol; Clofibrate; Female; Humans; Hypercholesterolemia; | 1972 |
Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. II. The effect of hydroxy bis-[2-(-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in hypercholesterolimic rats.
Topics: Adipose Tissue; Animals; Anticholesteremic Agents; Body Weight; Brain; Cholesterol; Cholesterol, Die | 1973 |
[Treatment of hyperlipoproteinemias (author's transl)].
Topics: Adolescent; Adult; Anticholesteremic Agents; Child; Cholestyramine Resin; Clofibrate; Dextrothyroxin | 1974 |
Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia.
Topics: Adenosine Diphosphate; Arteriosclerosis; Blood Platelets; Carbon Radioisotopes; Clofibrate; Collagen | 1974 |
[Current position in the treatment of arteriosclerosis].
Topics: Arteriosclerosis; Clofibrate; Diabetic Angiopathies; Diet Therapy; Humans; Hypercholesterolemia; Hyp | 1974 |
The influence of drugs affecting lipids on atherosclerosis.
Topics: Adult; Arteriosclerosis; Blood Protein Disorders; Clofibrate; Coronary Disease; Diabetes Complicatio | 1974 |
[Index of "unbound" thyroxine in patients with hypercholesterolemia or hypertriglyceridemia treated with clofibrate].
Topics: Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Thyroxine; Thy | 1972 |
An effective treatment of hypercholesterolaemia. Use of a combination of a bile acid sequestrant and clofibrate.
Topics: Chlorides; Cholestyramine Resin; Clofibrate; Drug Synergism; Humans; Hypercholesterolemia; Ion Excha | 1972 |
[Hypercholesteremia].
Topics: Cholesterol; Clofibrate; Diet Therapy; Dietary Fats; Humans; Hypercholesterolemia; Nicotinic Acids | 1972 |
[Classification and treatment of hyperlipidemia: normolipemic treatments in 1972].
Topics: Aluminum; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Triglycerides; Xanthomatosis | 1972 |
[Clinical and epidemiological aspects of human glyceridemia. IV. Etiological diagnosis and treatment of hyperglyceridemia. Practical aspects].
Topics: Alcohol Drinking; Body Weight; Clofibrate; Diet; Dietary Carbohydrates; Electrophoresis, Starch Gel; | 1972 |
Study of clofibrate in hypercholesterinemic rabbits and in arteriosclerotic subjects-modifications of platelet aggregation and fibrinolysis as related to lipidic fractions.
Topics: Animals; Arteriosclerosis; Blood Coagulation; Clofibrate; Dose-Response Relationship, Drug; Fibrinol | 1972 |
The combined use of clofibrate and anion exchange in the treatment of hypercholesterolemia.
Topics: Anion Exchange Resins; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Dextrans; Diet Therap | 1972 |
[Treatment of hyperlipidemia].
Topics: Clofibrate; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids | 1973 |
[Drugs which decrease serum lipids].
Topics: Clofibrate; Depression, Chemical; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Nicotinic A | 1973 |
An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate.
Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrans; Drug Synergism; E | 1973 |
[Hypolipemic agents].
Topics: Androgens; Biological Transport; Butyrates; Cholestyramine Resin; Clofibrate; Estrogens; Fatty Acids | 1973 |
Reversibility of lipid deposition.
Topics: Arteriosclerosis; Cholesterol; Clofibrate; Cornea; Coronary Disease; Coronary Vessels; Evaluation St | 1973 |
Atheromatous plaques of the retinal blood vessels. Histologic confirmation of ophthalmoscopically visible lesions.
Topics: Arteriosclerosis; Autopsy; Clofibrate; Heparin; Humans; Hypercholesterolemia; Hyperlipidemias; Male; | 1973 |
[The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
Topics: Adult; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Electropho | 1973 |
[Clinical experimentation of clofibride. Apropos of 40 cases].
Topics: Adult; Amides; Clofibrate; Diet; Drug Evaluation; Drug Interactions; Female; Humans; Hypercholestero | 1973 |
Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
Topics: Adult; Aged; Antigens; Blood Glucose; Blood Protein Disorders; Body Weight; Clofibrate; Fatty Acids, | 1974 |
Restraint of cholesterol accumulation in tissue pools associated with drastic short-term lowering of serum cholesterol levels by clofibrate or cholestyramine in hypercholesterolemic swine.
Topics: Animals; Bile Acids and Salts; Body Weight; Carbon Radioisotopes; Cholesterol; Cholesterol, Dietary; | 1974 |
Long-term treatment of hyperlipidemic patients with clofibrate.
Topics: Adult; Aged; Body Weight; Cholesterol; Clofibrate; Female; Glucose; Glucose Tolerance Test; Humans; | 1971 |
The effect of clofibrate on serum and faecal lipids.
Topics: Adult; Angina Pectoris; Bile Acids and Salts; Cholesterol; Clofibrate; Feces; Female; Humans; Hyperc | 1972 |
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Die | 1972 |
Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Carbon Isotopes; Child; Cholesterol; Cholestyramine Resin; | 1972 |
[Therapy of primary hyperlipidemias].
Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Heparin; Humans; Hypercholesterolemia; Hyperlipidemi | 1972 |
Thyrotropin immunoassay.
Topics: Clofibrate; Coronary Disease; Humans; Hypercholesterolemia; Thyrotropin | 1972 |
Drug treatment of hyperlipidemia.
Topics: Cholestyramine Resin; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Trigl | 1972 |
Primary prevention of atherosclerotic cardiovascular disease among Sabena flying personnel.
Topics: Aerospace Medicine; Arteriosclerosis; Cardiovascular Diseases; Clofibrate; Humans; Hypercholesterole | 1972 |
Serum lipid precursors of coronary heart disease.
Topics: Adult; Aged; Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholesterol; Cholestyramine Res | 1971 |
[Treatment of hyperlipoproteinemia in relation to recent classifications].
Topics: Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Thyroid Ho | 1971 |
[Results and prospects of the use of drugs acting on serum lipoproteins in atherosclerosis].
Topics: Arteriosclerosis; Clofibrate; Glycolates; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoprotein | 1971 |
[Action of Atromid-S on thrombogenic factors].
Topics: Animals; Anticholesteremic Agents; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; | 1971 |
Classification of hyperlipidaemias.
Topics: Carbohydrate Metabolism; Cholestyramine Resin; Chylomicrons; Clofibrate; Dextrothyroxine; Diabetes M | 1971 |
[Study of hepatic function before and after administration of therapeutic doses of clofibrate].
Topics: Adult; Aged; Alkaline Phosphatase; Arteriosclerosis; Bilirubin; Clofibrate; Female; Humans; Hypercho | 1971 |
[Diagnosis and therapy of familial hyper- -lipoproteinemia (familial hypercholesterolemia or familial hyperlipoproteinemia of type II)].
Topics: Adolescent; Cholestyramine Resin; Clofibrate; Dextrans; Diet Therapy; Female; Humans; Hypercholester | 1971 |
The chemotherapy of hypercholesterolaemia.
Topics: Aluminum; Androsterone; Anticholesteremic Agents; Clofibrate; Estrogens; Female; Humans; Hypercholes | 1969 |
[Effect of parachlorophenoxyisobutyric acid (CPIB acid) and of diet on blood cholesterol and on the beta-alpha lipoprotein ratio in aged subjects].
Topics: Age Factors; Aged; Anticholesteremic Agents; Cholesterol; Clofibrate; Diet Therapy; Female; Humans; | 1969 |
Clofibrate in biliary cirrhosis.
Topics: Anticholesteremic Agents; Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Liver Cirrhosis, Bi | 1970 |
[Drug therapy of hyperlipemia. Role of drugs at the disposition of general practitioners].
Topics: Cholestyramine Resin; Clofibrate; Estrogens; Family Practice; Humans; Hypercholesterolemia; Hyperlip | 1970 |
Clofibrate.
Topics: Anticholesteremic Agents; Clofibrate; Humans; Hypercholesterolemia; Hyperglycemia; Hyperlipidemias; | 1970 |
Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
Topics: Adult; Aged; Anticholesteremic Agents; Biopsy; Blood Proteins; Child; Cholesterol; Clofibrate; Coron | 1970 |
Diet and drugs in the treatment of hyperlipidemias.
Topics: Anticholesteremic Agents; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; H | 1970 |
[Unorthodox reflections about arteriosclerosis].
Topics: Animals; Arteriosclerosis; Cholesterol; Clofibrate; Heart Failure; Humans; Hypercholesterolemia; Hyp | 1970 |
Current attempts at prevention of ischaemic heart disease.
Topics: Adult; Anticholesteremic Agents; Clofibrate; Coronary Disease; Diet Therapy; England; Humans; Hyperc | 1971 |
Effect of atromid-S and high fat diet on lipid contents and lipolysis in rat tissues and serum.
Topics: Anticholesteremic Agents; Body Weight; Cholesterol; Clofibrate; Dietary Fats; Hypercholesterolemia; | 1971 |
Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
Topics: Angina Pectoris; Blood Protein Disorders; Blood Protein Electrophoresis; Body Weight; Cholesterol; C | 1971 |
[Experimental lipoidosis of the aorta in rabbits with endogenous hypercholesteremia and without anisotropic adiposis of the liver].
Topics: Adipose Tissue; Aminocaproates; Animals; Aorta; Cholesterol; Clofibrate; Dietary Fats; Disease Model | 1971 |
Diet and drug therapy for hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Body Weight; Cholestyramine Resin; Clofibrate; Diet Therapy; Dietary Carbo | 1971 |
Radiographic visualization of arterial lesions in cholesterol-fed rabbits. Effect of clofibrate, and of return to normal diet on serum cholesterol, and on lesion status.
Topics: Angiography; Animals; Anticholesteremic Agents; Aorta; Aortography; Arteriosclerosis; Cholesterol; C | 1971 |
[Therapy of primary hyperlipemia].
Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Diet, Reducing; | 1971 |